Table 2.

Survival analysis.

	Univariate analysis		Multivariate analysis
	5-year OS (95% CI)	p value	HR (95% CI)	p value
Gender			–
Male	62.1 (49.7–72.2)
Female	75.2 (50.2–88.9)	0.56
Age			–
<59	64.9 (49.4–76.7)
>58	63.1 (46.9–75.5)	0.98
Remnant
No	65.0 (52.8–74.8)		Reference
Yes	47.9 (20.0–71.4)	0.02	2.99 (1.22–7.36)	0.017
Size (cm)
<4.3	68.9 (45.3–84.0)		Reference
>4.2	59.7 (46.6–70.6)	0.03	1.25 (0.58–2.67)	0.57
Lauren
Diffuse + Mix	58.2 (43.6–70.3)		Reference
Intestine	88.6 (71.9–95.7)	0.03	2.69 (0.93–7.83)	0.068
HER2			–
Positive	50.0 (11.1–80.4)
Negative	62.0 (48.8–72.7)	0.21
TNM stage
I	90.7 (63.8–97.9)		Reference
II	85.8 (53.3–96.3)		2.54 (0.23–28.39)
III	61.4 (45.2–74.2)		8.72 (1.13–67.09)
IV	17.1 (3.5–39.3)	<0.001	37.98 (4.88–295.34)	<0.001

–: not involved in the multivariate analysis.

CI, confidence interval; HER2, human epidermal growth factor receptor 2; OS, overall survival; TNM, tumor-node-metastasis.